Marc André

1.5k total citations · 1 hit paper
19 papers, 1.0k citations indexed

About

Marc André is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc André has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc André's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Marc André is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Marc André collaborates with scholars based in France, Belgium and United States. Marc André's co-authors include É. Lechevallier, Laurent Daniel, Christian Coulange, Y. Neuzillet, Dominique Rossi, C. Eghazarian, Marc de Fromont, Aleš Obr, Johannes Weirather and Kami J. Maddocks and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Radiology.

In The Last Decade

Marc André

17 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

2020 324 citations Gilles Salles, Johannes Duell et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc André France	8	439	436	435	363	143	19	1.0k
Juliana Di Iulio Australia	16	645 1.5×	223 0.5×	314 0.7×	318 0.9×	254 1.8×	34	1.1k
M. Luisa Paccagnella United States	13	857 2.0×	275 0.6×	283 0.7×	409 1.1×	143 1.0×	22	1.7k
Junning Cao China	16	553 1.3×	213 0.5×	381 0.9×	136 0.4×	109 0.8×	90	907
M. Testi Italy	19	244 0.6×	296 0.7×	167 0.4×	289 0.8×	166 1.2×	62	983
Marcelo Scopinaro Argentina	18	528 1.2×	519 1.2×	268 0.6×	255 0.7×	88 0.6×	30	1.5k
Tipu Nazeer United States	20	412 0.9×	579 1.3×	364 0.8×	318 0.9×	100 0.7×	70	1.4k
Igor Aurer Croatia	20	449 1.0×	187 0.4×	531 1.2×	139 0.4×	223 1.6×	88	950
Simone Ferrero Italy	18	462 1.1×	176 0.4×	583 1.3×	347 1.0×	270 1.9×	82	1.3k
Mars B. van ’t Veer Netherlands	15	356 0.8×	198 0.5×	536 1.2×	181 0.5×	284 2.0×	36	1.4k
Marie Maerevoet Belgium	15	415 0.9×	131 0.3×	179 0.4×	153 0.4×	147 1.0×	40	820

Countries citing papers authored by Marc André

Since Specialization

Citations

This map shows the geographic impact of Marc André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc André more than expected).

Fields of papers citing papers by Marc André

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc André. The network helps show where Marc André may publish in the future.

Co-authorship network of co-authors of Marc André

This figure shows the co-authorship network connecting the top 25 collaborators of Marc André. A scholar is included among the top collaborators of Marc André based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc André. Marc André is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Clément, Melissa, Claude Dubray, M. Ruivard, et al.. (2024). Amoxicillin Blood Concentration in High-Dose Intravenous Discontinuous Amoxicillin: Look Beyond Numbers. Max-Amox Study. Clinical Therapeutics. 47(3). 212–218.

Snauwaert, Sylvia, et al.. (2023). Real-World Effectiveness and Safety of Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) in Belgium after 4 Years. Blood. 142(Supplement 1). 6550–6550.

Desbois, A.C., Bastien Joubert, Cécile‐Audrey Durel, et al.. (2022). Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up.. SPIRE - Sciences Po Institutional REpository. 1 indexed citations

Salles, Gilles, Johannes Duell, Eva González‐Barca, et al.. (2020). Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study. The Lancet Oncology. 21(7). 978–988. 324 indexed citations breakdown →

Sureda, Anna, Marc André, Peter Borchmann, et al.. (2020). Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective. BMC Cancer. 20(1). 1088–1088. 7 indexed citations

Baboudjian, Michaël, Bastien Gondran‐Tellier, F. Michel, et al.. (2019). MRI-targeted biopsy for detecting prostate cancer: have the guidelines changed our practices and our prostate cancer detection rate?. International Urology and Nephrology. 52(4). 611–618. 6 indexed citations

Depaus, Julien, A Delcourt, & Marc André. (2018). Therapeutic recommendations for early stage Hodgkin lymphomas. British Journal of Haematology. 184(1). 9–16. 3 indexed citations

Devos, Timothy, Koen Theunissen, Fleur Samantha Benghiat, et al.. (2018). Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients in Real-World Clinical Practice: Data from a Belgian Registry. Blood. 132(Supplement 1). 1744–1744. 3 indexed citations

Gladstone, Douglas E., Marc André, Jan Maciej Zaucha, et al.. (2014). Phase 2 open-label study of MEDI-551 and bendamustine versus rituximab and bendamustine in adults with relapsed or refractory CLL.. Journal of Clinical Oncology. 32(15_suppl). 3028–3028. 3 indexed citations

10.

Forero, Andres, Mehdi Hamadani, Thomas J. Kipps, et al.. (2013). Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. Journal for ImmunoTherapy of Cancer. 1(S1). 3 indexed citations

11.

André, Marc. (2013). Combination Chemoradiotherapy in Early Hodgkin Lymphoma. Hematology/Oncology Clinics of North America. 28(1). 33–47. 1 indexed citations

12.

André, Marc, et al.. (2010). Clostridium tertium bacteremia: contamination or true pathogen? A report of two cases and a review of the literature. International Journal of Infectious Diseases. 14. e335–e337. 24 indexed citations

13.

Méjean, Arnaud, Marc André, J.-D. Doublet, et al.. (2004). [Kidney tumors].. PubMed. 14(4 Suppl 1). 997, 999–1035. 1 indexed citations

14.

Neuzillet, Y., É. Lechevallier, Marc André, Laurent Daniel, & Christian Coulange. (2004). Accuracy and Clinical Role of Fine Needle Percutaneous Biopsy With Computerized Tomography Guidance of Small (Less Than 4.0 Cm) Renal Masses. The Journal of Urology. 171(5). 1802–1805. 233 indexed citations

15.

André, Marc, et al.. (2001). Two Enlarged Kidneys: A Manifestation of Erdheim-Chester Disease. American Journal of Nephrology. 21(4). 315–317. 26 indexed citations

16.

Lechevallier, É., Marc André, Laurent Daniel, et al.. (2000). Fine-Needle Percutaneous Biopsy of Renal Masses with Helical CT Guidance. Radiology. 216(2). 506–510. 163 indexed citations

17.

Lechevallier, É., et al.. (2000). [CT-guided percutaneous fine needle biopsy of solid tumors of the kidney].. PubMed. 10(6). 1145–51. 8 indexed citations

18.

André, Marc, M. Henry‐Amar, José-Luis Pico, et al.. (1999). Comparison of High-Dose Therapy and Autologous Stem-Cell Transplantation With Conventional Therapy for Hodgkin's Disease Induction Failure: A Case-Control Study. Journal of Clinical Oncology. 17(1). 222–222. 118 indexed citations

19.

André, Marc, M. Henry‐Amar, Didier Blaise, et al.. (1998). Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.. Blood. 92(6). 1933–40. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact